Claudio A. Naranjo
- Cellular and Molecular Neuroscience top 1%
- Psychiatry and Mental health top 1%
- Neurology top 1%
- Epidemiology top 2%
- Pharmacology top 1%
- Co-authors
- Edward M. SellersKathy SykoraJohn T. SullivanJoyce SchneidermanKrista L. LanctôtUsoa E. BustoUsoa BustoNathan Herrmann
- Topics
- Neurotransmitter Receptor Influence on Behavior (20 papers)Pharmacovigilance and Adverse Drug Reactions (15 papers)Treatment of Major Depression (14 papers)
- Partner nations
- CanadaUnited StatesChile
In The Last Decade
Claudio A. Naranjo
88 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Cellular and Molecular Neuroscience 1.5k
- Psychiatry and Mental health 1.2k
- Neurology 1.1k
- Epidemiology 994
- Pharmacology 906
Countries citing papers authored by Claudio A. Naranjo
This map shows the geographic impact of Claudio A. Naranjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio A. Naranjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio A. Naranjo more than expected).
Fields of papers citing papers by Claudio A. Naranjo
This network shows the impact of papers produced by Claudio A. Naranjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio A. Naranjo. The network helps show where Claudio A. Naranjo may publish in the future.
Co-authorship network of co-authors of Claudio A. Naranjo
This figure shows the co-authorship network connecting the top 25 collaborators of Claudio A. Naranjo. A scholar is included among the top collaborators of Claudio A. Naranjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio A. Naranjo. Claudio A. Naranjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | Pharmacokinetic Applications of Fuzzy Structure Identification and Reasoning | 1 |
| 3 | 19 | |
| 4 | Fuzzy System Modeling in Pharmacology: An Improved Algorithm | 3 |
| 5 | 45 | |
| 6 | 41 | |
| 7 | 102 | |
| 8 | 10 | |
| 9 | 98 | |
| 10 | El eneagrama de la sociedad: males del mundo, males del alma | 2 |
| 11 | 66 | |
| 12 | 16 | |
| 13 | 29 | |
| 14 | 32 | |
| 15 | 88 | |
| 16 | 10 | |
| 17 | 170 | |
| 18 | Ayahuasca imagery and the therapeutic property of harmala alkaloids. | 5 |
| 19 | 50 | |
| 20 | 18 |
About Claudio A. Naranjo
Claudio A. Naranjo is a scholar working on Toxicology, Pharmacology and Pharmacology, having authored 89 papers that have together received 5.4k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (20 papers), Pharmacovigilance and Adverse Drug Reactions (15 papers) and Treatment of Major Depression (14 papers). The work is most often cited by research in Toxicology (284 citations), Cellular and Molecular Neuroscience (1.5k citations) and Psychiatry and Mental health (1.2k citations). Claudio A. Naranjo has collaborated with scholars based in Canada, United States and Chile. Frequent co-authors include Edward M. Sellers, Kathy Sykora, John T. Sullivan, Joyce Schneiderman, Krista L. Lanctôt, Usoa E. Busto, Usoa Busto, Nathan Herrmann, Martha Sanchez‐Craig and K Kadlec. Their work appears in journals such as Nature, New England Journal of Medicine and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.